Browse our comprehensive collection of market intelligence reports.
The biomarker-based disease detection market enables early disease diagnosis, prognosis, and personalized therapy by identifying genetic, proteomic, or metabolic markers. Adoption is driven by rising chronic disease prevalence, precision medicine initiatives, and technological advances in molecular diagnostics. Hospitals, research institutions, and pharmaceutical companies increasingly rely on biomarker testing for improved patient outcomes.
The digital pathology and AI assisted microscopy market integrate high resolution imaging, cloud platforms, and artificial intelligence to enhance specimen analysis, disease classification, and diagnostic accuracy. Public health strategies increasingly support digital diagnostic tools to address rising disease burdens and improve care quality.